Description
KLOW extends the GLOW composition by adding KPV, a melanocortin-derived tripeptide investigated in inflammatory bowel and epithelial transport models.
What it is
KLOW extends the GLOW framework by adding KPV, creating a four-component blend aimed at inflammation-plus-repair hypothesis work.
Mechanism snapshot
- Combines regenerative signaling concepts from BPC/GHK/TB components.
- Adds KPV anti-inflammatory pathway hypotheses from intestinal models.
- Supports exploratory multi-axis protocol design in preclinical contexts.
Research programs
- Inflammation and matrix-repair blend comparisons.
- KPV transport and signaling integration studies.
- Component-attribution analysis in multi-agent frameworks.
Limitations
- Complex multi-component behavior can reduce predictability.
- No broad high-quality trial base for the exact formula.
- Claims should remain constrained to investigational context.
Selected references
- Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease - PubMed 2008
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation - PubMed 2008
- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration - PubMed 2015
Ordering
Add this item to your cart, submit your shipping details at checkout, and wait for your order confirmation. Interac e-Transfer instructions are sent after the order request is received.


